Levofloxacin: Is It Still Suitable as an Empirically used Antibiotic During the Perioperative Period of Flexible Ureteroscopic Lithotripsy? A Single-center Experience with 754 Patients
1 January 2020
Purpose: To determine the empirical usage of antibiotics and analyze the pathogen spectrum during the perioperative period of flexible ureteroscopic lithotripsy (FURSL) with a focus on levofloxacin.
Materials and Methods: This retrospective analysis included 754 patients who underwent FURSL successfully in our hospital from January 2015 to July 2019. All patients were indicated urine cultures and prescribed antibiotics during the perioperative period. Patients with negative preoperative urine cultures were divided into levofloxacin (LVXG) and non-levofloxacin groups (NLVXG) based on the empirical use of antibiotics. Operative time, the length of postoperative hospital stays and total hospital stays, total hospitalization costs, postoperative fever rate and removal rate of stones were compared. Patients with positive urine cultures were analyzed for pathogen distribution and antibiotic resistance.
Results: In the empirical use of antibiotics among 541 cases with negative urine cultures, the prescription rate of levofloxacin was 68.95%. Compared to that in NLVXG, LVXG had a lower cost of antibiotics but higher postoperative fever rate and longer hospital stay. There were no significant differences in operative time, the total hospitalization costs and the removal rate of stones between the two groups. The top two common pathogens were Escherichia coli (36.11%) and Enterococcus faecalis (24.07%), with resistance rates of 74.36% and 71.15% to levofloxacin, respectively.
Conclusion: Levofloxacin might be no longer suitable as the first-line choice of clinical experience when performing FURSL in our center.
- flexible ureteroscopic lithotripsy
- urine culture
How to Cite
Zeng G, Mai Z, Xia S, et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int. 2017;120:109-16.
Komori M, Izaki H, Daizumoto K, et al. Complications of Flexible Ureteroscopic Treatment for Renal and Ureteral Calculi during the Learning Curve. Urol Int. 2015;95:26-32.
Xu K, Ding J, Shi B, Wu Y, Huang Y. Flexible ureteroscopic holmium laser lithotripsy with PolyScope for senile patients with renal calculi. Exp Ther Med. 2018;16:1723-8.
Carlos EC, Youssef RF, Kaplan AG, et al. Antibiotic Utilization Before Endourological Surgery for Urolithiasis: Endourological Society Survey Results. J Endourol. 2018;32:978-85.
Jang WH, Yoo DH, Park SW. Prevalence of and Risk Factors for Levofloxacin-Resistant E. coli Isolated from Outpatients with Urinary Tract Infection. Korean J Urol. 2011;52:554-9.
Wu YH, Chen PL, Hung YP, Ko WC. Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections. J Microbiol Immunol Infect. 2014;47:197-203.
Wu HH, Liu HY, Lin YC, Hsueh PR, Lee YJ. Correlation between levofloxacin consumption and the incidence of nosocomial infections due to fluoroquinolone-resistant Escherichia coli. J Microbiol Immunol Infect. 2016;49:424-9.
Senocak C, Ozcan C, Sahin T, et al. Risk Factors of Infectious Complications after Flexible Uretero-renoscopy with Laser Lithotripsy. Urol J. 2018;15:158-63.
Taguchi K, Cho SY, Ng AC, et al. The Urological Association of Asia clinical guideline for urinary stone disease. Int J Urol. 2019;26:688-709.
Zetumer S, Wiener S, Bayne DB, et al. The Impact of Stone Multiplicity on Surgical Decisions for Patients with Large Stone Burden: Results from ReSKU. J Endourol. 2019;33:742-9.
Hyams ES, Monga M, Pearle MS, et al. A prospective, multi-institutional study of flexible ureteroscopy for proximal ureteral stones smaller than 2 cm. J Urol. 2015;193:165-9.
Pieras E, Tubau V, Brugarolas X, Ferrutxe J, Piza P. Comparative analysis between percutaneous nephrolithotomy and flexible ureteroscopy in kidney stones of 2-3cm. Actas Urol Esp. 2017;41:194-9.
Zhu Z, Cui Y, Zeng F, Li Y, Chen Z, Hequn C. Comparison of suctioning and traditional ureteral access sheath during flexible ureteroscopy in the treatment of renal stones. World J Urol. 2019;37:921-9.
El-Nahas AR, Almousawi S, Alqattan Y, Alqadri IM, Al-Shaiji TF, Al-Terki A. Dusting versus fragmentation for renal stones during flexible ureteroscopy. Arab J Urol. 2019;17:138-42.
Berardinelli F, De Francesco P, Marchioni M, et al. Infective complications after retrograde intrarenal surgery: a new standardized classification system. Int Urol Nephrol. 2016;48:1757-62.
Chen Y, Liao B, Feng S, et al. Comparison of Safety and Efficacy in Preventing Postoperative Infectious Complications of a 14/16F Ureteral Access Sheath with a 12/14F Ureteral Access Sheath in Flexible Ureteroscopic Lithotripsy. J Endourol. 2018;32:923-7.
Hu H, Lu Y, He D, et al. Comparison of minimally invasive percutaneous nephrolithotomy and flexible ureteroscopy for the treatment of intermediate proximal ureteral and renal stones in the elderly. Urolithiasis. 2016;44:427-34.
Koras O, Bozkurt IH, Yonguc T, et al. Risk factors for postoperative infectious complications following percutaneous nephrolithotomy: a prospective clinical study. Urolithiasis. 2015;43:55-60.
Singh P, Yadav S, Singh A, et al. Systemic Inflammatory Response Syndrome Following Percutaneous Nephrolithotomy: Assessment of Risk Factors and Their Impact on Patient Outcomes. Urol Int. 2016;96:207-11.
Deng T, Liu B, Duan X, et al. Antibiotic prophylaxis in ureteroscopic lithotripsy: a systematic review and meta-analysis of comparative studies. BJU Int. 2018;122:29-39.
Whitehurst L, Jones P, Somani BK. Mortality from kidney stone disease (KSD) as reported in the literature over the last two decades: a systematic review. World J Urol. 2019;37:759-76.
Lo CW, Yang SS, Hsieh CH, Chang SJ. Effectiveness of Prophylactic Antibiotics against Post-Ureteroscopic Lithotripsy Infections: Systematic Review and Meta-Analysis. Surg Infect (Larchmt). 2015;16:415-20.
Wang SS, Ratliff PD, Judd WR. Retrospective review of ceftriaxone versus levofloxacin for treatment of E. coli urinary tract infections. Int J Clin Pharm. 2018;40:143-9.
Lin HA, Yang YS, Wang JX, et al. Comparison of the effectiveness and antibiotic cost among ceftriaxone, ertapenem, and levofloxacin in treatment of community-acquired complicated urinary tract infections. J Microbiol Immunol Infect. 2016;49:237-42.
Ramos Lazaro J, Smithson A, Jove Vidal N, Batida Vila MT. Clinical predictors of ceftriaxone resistance in microorganisms causing febrile urinary tract infections in men. Emergencias. 2018;30:21-7.
Chua KYL, Stewardson AJ. Individual and community predictors of urinary ceftriaxone-resistant Escherichia coli isolates, Victoria, Australia. Antimicrob Resist Infect Control. 2019;8:36.
Miglis C, Rhodes NJ, Avedissian SN, et al. A Simple Microsoft Excel Method to Predict Antibiotic Outbreaks and Underutilization. Infect Control Hosp Epidemiol. 2017;38:860-2.
Saidian A, Nix JW. Enhanced Recovery After Surgery: Urology. Surg Clin North Am. 2018;98:1265-74.
Nevo A, Mano R, Shoshani O, Kriderman G, Schreter E, Lifshitz D. Stone culture in patients undergoing percutaneous nephrolithotomy: a practical point of view. Can J Urol. 2018;25:9238-44.
- Abstract Viewed: 0 times
- Just Accepted/6033 Downloaded: 0 times